Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
12,394
Price
$16.33
Total Value
$202,437.40
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Sep 16, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Sep 18, 2026 |
| Shares Sold | 12,394 |
| Price per Share | $16.33 |
| Total Value | $202,437.40 |
| Shares Owned After | 39,900 |
| Derivative | No |
| Accession Number | 0001810417-26-000023 |
| Document | View SEC Filing |